The effect of prenatal drug exposure and caregiving context on children's performance on a task of sustained visual attention

Journal of Developmental and Behavioral Pediatrics

Volumn 29, Issue 6, 2008, Pages 467-474

  Ackerman, John P ^a   Llorente, Antolin M ^a   Black, Maureen M ^a,b   Ackerman, Claire S ^a   Mayes, Lacy A ^a   Nair, Prasanna ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Conners' CPT; Prenatal drug exposure; Sustained visual attention

Indexed keywords

ACADEMIC ACHIEVEMENT; ARTICLE; AUTOREGULATION; BIRTH WEIGHT; CAREGIVER SUPPORT; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; DRUG ABUSE; FEMALE; GESTATIONAL AGE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; NEUROPSYCHOLOGY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SCHOOL CHILD; TASK PERFORMANCE; URBAN AREA; ADDICTION; ADULT; ANALYSIS OF VARIANCE; ATTENTION; CAREGIVER; CHILD DEVELOPMENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; FOLLOW UP; MOTHER CHILD RELATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SOCIOECONOMICS; STATISTICS; VISION;

ADULT; ANALYSIS OF VARIANCE; ATTENTION; CAREGIVERS; CHILD; CHILD DEVELOPMENT; COGNITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MOTHER-CHILD RELATIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TASK PERFORMANCE AND ANALYSIS; VISUAL PERCEPTION;

EID: 59149097541     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e3181903168     Document Type: Article

References (57)

1. Kim J, Krall J. Literature Review: Effects of Prenatal Substance Exposure on Infant and Early Childhood Outcomes. Berkley, CA: National Abandoned Infants Assistance Resource Center, University of California at Berkeley; 2006.
2. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA. 2001;285: 1613-1625.
3. Brown JV, Bakeman R, Coles CD, Platzman KA, Lynch ME. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and nonparental care. Child Dev. 2004;75:1282-1295.
4. Shonkoff JP, Phillips DA. From Neurons to Neighborhoods: The Science of Early Childhood Development. Washington D. C.: National Academy Press; 2000.
5. Accornero VH, Amado AJ, Morrow CE, Xue L, Anthony JC, Bandstra ES. Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests. J Dev Behav Pediatr. 2007;28:195-205.
6. Arendt R, Short E, Singer LT, et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr. 2004;25:83-90.
7. Hurt H, Brodsky NL, Roth H, Malmud E, Giannetta JM. School performance of children with gestational cocaine exposure. Neurotoxicol Teratol. 2005;27:203-211.
8. Nair P, Black M, Ackerman J, Schuler M, Keane V. Children's cognitive-behavioral functioning at age 6 and 7: prenatal drug exposure and caregiving environment. Ambul Pediatr. 2008;8: 154-162.
9. Singer LT, Minnes S, Short E, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA. 2004; 291:2448-2456.
10. Messinger DS, Bauer CR, Das A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics. 2004;113:1677-1685.
11. Bada HS, Das A, Bauer CR, et al. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics. 2007;119:e348-e359.
12. Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol. 2001;23:545-559.
13. Hickey JE, Suess PE, Newlin DB, Spurgeon L, Porges SW. Vagal tone regulation during sustained attention in boys exposed to opiates in utero. Addict Behav. 1995;20:43-59.
14. Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H. Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr. 2005;26:42-47.
15. Beeghly M, Martin B, Rose-Jacobs R, et al. Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: Moderating effects of child age, birthweight, and gender. J Pediatr Psychol. 2006;31:98-115.
16. Heffelfinger A, Craft S, Shyken J. Visual attention in children with prenatal cocaine exposure. J Int Neuropsychol Soc. 1997;3:237- 245.
17. Mayes LC, Grillon C, Granger R, Schottenfeld R. Regulation of arousal and attention in preschool children exposed to cocaine prenatally. Ann N Y Acad Sci. 1998;846:126-143.
18. Noland JS, Singer LT, Short EJ, et al. Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol. 2005; 27:429-438.
19. Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: Effects on the development of school-age children. Neurotoxicol Teratol. 1996;18:627-634.
20. Malanga C, Kosofsky B. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin Perinatol. 1999;26:17-37.
21. Mayes LC. A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotoxicol Teratol. 2002;24:385-395.
22. Seidler FJ, Temple SW, McCook EC, Slotkin TA. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. Dev Brain Res. 1995;85:48-53.
23. Stanwood GD, Washington RA, Shumsky JS, Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience. 2001;106:5-14.
24. Glatt SJ, Bolanos CA, Trksak GH, Jackson D. Effects of prenatal cocaine exposure on dopamine system development: A meta-analysis. Neurotoxicol Teratol. 2000;22:617-629.
25. Lidow MS, Song Z. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol. 2001;435:263-275.
26. Mayes LC, Molfese DL, Key APF, Hunter NC. Event-related potentials in cocaine-exposed children during a Stroop task. Neurotoxicol Teratol. 2005;27:797-813.
27. Ornoy A, Segal J, Bar-Hamburger R, Greenbaum C. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol. 2001;43:668-675.
28. Bendersky M, Gambini G, Lastella A, Bennett D, Lewis M. Inhibitory motor control at five years as a function of prenatal cocaine exposure. J Dev Behav Pediatr. 2003;24:345-351.
29. Minnes S, Singer LT, Arendt R, Satayathum S. Effects of prenatal cocaine/polydrug use on maternal-infant feeding interactions during the first year of life. J Dev Behav Pediatr. 2005;26:194- 200.
30. Black MM, Nair P, Kight C, Wachtel R, Roby P, Schuler M. Parenting and early development among children of drug-abusing women: effects of home intervention. Pediatrics. 1994;94:440- 448.
31. Barth RP, Brooks D. Outcomes for drug-exposed children eight years post-adoption. In: Barth RP, Brodzinsky D, Freundlich M, eds. Adoption and Prenatal Drug Exposure: The Research, Policy and Practice Challenges. Washington, DC: Child Welfare League of America; 2001:23-58.
32. Landsverk J, Davis I, Ganger W, Newton R. Impact of child psychosocial functioning on reunification from out-of-home placement. Child Youth Serv Rev. 1996;18:447-462.
33. Lewis E, Dozier M, Ackerman J, Sepulveda-Kozakowski S. The effect of placement instability on adopted children's inhibitory control abilities and oppositional behavior. Dev Psych. 2007;43: 1415-1427.
34. Schuler M, Nair P, Black M. Ongoing maternal drug use, parenting attitudes, and a home intervention: effects on mother-child interaction at 18 months. J Dev Behav Pediatr. 2002;23:87-94.
35. McLellan A, Luborsky L, O'Brien C, Woody G. An improved diagnostic instrument for substance abuse patients: the addiction severity index. J Nerv Ment Dis. 1980;168:26-33.
36. Enhancing the outcomes of low-birth-weight, premature infants. A multisite, randomized trial. The Infant Health and Development Program. JAMA. 1990;263:3035-3042.
37. Conners CK. The Conners Continuous Performance Test. Toronto, Canada: Multi-Health Systems; 1994.
38. Stanford- Binet Intelligence Scales. 4th ed. Chicago: The Riverside Publishing Company; 1987.
39. Wilkinson G. Wide range achievement test-revision 3. In: Lutz, ed. FL: Psychological Assessment Resources; 2001.
40. Achenbach TM. Manual for Child Behavior Checklist and 1991 Profile. Burlington: University of Vermont; 1991.
41. Oken E, Kleinman K, Rich-Edwards J, Gillman M. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6.
42. Shenkin SD, Starr JM, Deary IJ. Birth weight and cognitive ability in childhood: a systematic review. Psychol Bull. 2004;130:989-1013.
43. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1: 385-401.
44. Kaufman A, Kaufman N. Kaufman brief intelligence test (K-BIT). In: Bloomington, MN, ed.: Pearson Assessments; 1990.
45. Grados JJ, Russo-Garcia KA. Comparison of the Kaufman Brief Intelligence Test and the Wechsler Intelligence Scale for Children - third edition in economically disadvantaged African American youth. J Clin Psychol. 1999;55:1063-1071.
46. Bendersky M, Lewis M. Prenatal cocaine exposure and impulse control at two years. Ann N Y Acad Sci. 1998;846:365-367.
47. Coles CD, Bard KA, Platzman KA, Lynch ME. Attentional response at eight weeks in prenatally drug-exposed and preterm infants. Neurotoxicol Teratol. 1999;21:527-537.
48. Karmel BZ, Gardner JM. Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. Dev Psychobiol. 1996;29:463-480.
49. Schuler ME, Nair P, Black MM, Kettinger L. Mother-infant interaction: effects of a home intervention and ongoing maternal drug use. J Clin Child Psychol. 2000;29:424-431.
50. Landry SH, Miller-Loncar CL, Smith KE, Swank PR. The role of early parenting in children's development of executive processes. Dev Neuropsychol. 2002;21:15-41.
51. Llorente AM, Amado A, Voigt RG, et al. Internal consistency, temporal stability, and reproducibility of individual index scores of the Test of Variables of Attention (T.O.V.A.) in children with attention-deficit/ hyperactivity disorder. Arch Clin Neuropsychol. 2001;16:535-546.
52. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. New York: Guilford; 1998.
53. Leark RA, Dupuy TR, Greenberg LM, Corman CL, Kindschi CL. Test of Variables of Attention Professional Manual. Los Alimitos, CA: Universal Attention Disorders; 1996.
54. Watson SMR, Westby CE. Strategies for addressing the executive function impairments of students prenatally exposed to alcohol and other drugs. Commun Dis Q. 2003;24: 194-204.
55. Delaney-Black V, Covington C, Nordstrom B, et al. Prenatal cocaine: Quantity of exposure and gender moderation. J Dev Behav Pediatr. 2004;25:245-63.
56. Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: Drug use by meconium toxicology and maternal self-report. Pediatr. 2001;107:309-17.
57. NICHD. Duration and developmental timing of poverty and children's cognitive and social development from birth through third grade. Child Dev. 2005;76:795-810.